(Circulation. 1995;92:1612-1618.)
© 1995 American Heart Association, Inc.
Articles |
Response of Failing Canine and Human Heart Cells to ß2-Adrenergic Stimulation
From the Departments of Medical Biochemistry (R.A.A., J.H., L.C., C.M.H.), Physiology (G.E.B.), Pharmacology (R.H.F.), Radiology (P.-M.L.R.), Internal Medicine (Division of Cardiology) (R.C.S.), and Veterinary Physiology and Pharmacology (R.L.H.), Ohio State University, Columbus; Krannert Institute of Cardiology, University of Indiana, Indianapolis (L.R.J.); and the Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, Baltimore, Md (R.-P.X., E.G.L.).
Correspondence to Dr Ruth A. Altschuld, Ohio State University, Department of Medical Biochemistry, 333 Hamilton Hall, 1645 Neil Ave, Columbus OH 43210-1218. E-mail raltschu@magnus.acs.ohio-state.edu.
Background Failing human hearts lose ß1- but not ß2-adrenergic receptors. In canine hearts with tachypacing failure, the ratio of ß2- to ß1-adrenergic receptors is increased. The present study was designed to determine whether heart failure increases sensitivity to ß2-adrenergic stimulation in isolated canine ventricular cardiomyocytes and to verify that myocytes from failing human ventricles contain functional ß2-adrenergic receptors.
Methods and Results Myocytes from healthy dogs, dogs with tachypacing failure, and human transplant recipients were loaded with fura 2-AM and subjected to electric field stimulation in the presence of zinterol, a highly selective ß2-adrenergic agonist. Zinterol significantly increased [Ca2+]i transient amplitudes in all three groups. The failing canine myocytes were significantly more responsive than normal to ß2-adrenergic stimulation. We also measured isotonic twitches, indo-1 fluorescence transients, and L-type Ca2+ currents in healthy canine myocytes. Zinterol (10-5 mol/L) elicited large increases in the amplitudes of simultaneously recorded twitches and [Ca2+]i transients. Zinterol also increased L-type Ca2+ currents in the normal canine myocytes; this augmentation was abolished by 10-7 mol/L ICI 118,551. cAMP production by suspensions of healthy and failing canine myocytes was not increased by zinterol (10-9 to 10-5 mol/L), nor did 10-5 mol/L zinterol elicit phospholamban phosphorylation.
Conclusions Failing human ventricular cardiomyocytes contain functional ß2-adrenergic receptors. Canine myocytes also contain functional ß2-adrenergic receptors. The canine ventricular response to ß2-agonists is increased in tachypacing failure. Positive inotropic responses to ß2-stimulation are not mediated by increases in cAMP or cAMP-dependent phosphorylation of phospholamban.
Key Words: calcium channels • cells • heart failure • myocardial contraction • receptors, adrenergic, beta • sarcoplasmic reticulum
This article has been cited by other articles:
 |
|
 |
|
  J. DeSantiago, X. Ai, M. Islam, G. Acuna, M. T. Ziolo, D. M. Bers, and S. M. Pogwizd Arrhythmogenic Effects of {beta}2-Adrenergic Stimulation in the Failing Heart Are Attributable to Enhanced Sarcoplasmic Reticulum Ca Load Circ. Res., June 6, 2008; 102(11): 1389 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. L. Lujan and S. E. DiCarlo T5 spinal cord transection increases susceptibility to reperfusion-induced ventricular tachycardia by enhancing sympathetic activity in conscious rats Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3333 - H3339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Holycross, M. Kukielka, Y. Nishijima, R. A. Altschuld, C. A. Carnes, and G. E. Billman Exercise training normalizes beta-adrenoceptor expression in dogs susceptible to ventricular fibrillation Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2702 - H2709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Barbato, M. Penicka, L. Delrue, F. Van Durme, B. De Bruyne, M. Goethals, W. Wijns, M. Vanderheyden, and J. Bartunek Thr164Ile polymorphism of {beta}2-adrenergic receptor negatively modulates cardiac contractility: implications for prognosis in patients with idiopathic dilated cardiomyopathy Heart, July 1, 2007; 93(7): 856 - 861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. E. Billman, M. Kukielka, R. Kelley, M. Moustafa-Bayoumi, and R. A. Altschuld Endurance exercise training attenuates cardiac beta2-adrenoceptor responsiveness and prevents ventricular fibrillation in animals susceptible to sudden death Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2590 - H2599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-Q. He, R. C. Balijepalli, R. A. Haworth, and T. J. Kamp Crosstalk of {beta}-Adrenergic Receptor Subtypes Through Gi Blunts {beta}-Adrenergic Stimulation of L-Type Ca2+ Channels in Canine Heart Failure Circ. Res., September 16, 2005; 97(6): 566 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Foerster, F. Groner, J. Matthes, W. J. Koch, L. Birnbaumer, and S. Herzig Cardioprotection specific for the G protein Gi2 in chronic adrenergic signaling through {beta}2-adrenoceptors PNAS, November 25, 2003; 100(24): 14475 - 14480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Lohse, S. Engelhardt, and T. Eschenhagen What Is the Role of {beta}-Adrenergic Signaling in Heart Failure? Circ. Res., November 14, 2003; 93(10): 896 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Velez-Roa, M. Renard, J.-P. Degaute, and P. van de Borne Peripheral sympathetic control during dobutamine infusion: effects of aging and heart failure J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1605 - 1610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Pavoine, N. Behforouz, C. Gauthier, S. Le Gouvello, F. Roudot-Thoraval, C. R. Martin, A. Pawlak, C. Feral, N. Defer, R. Houel, et al. {beta}2-Adrenergic Signaling in Human Heart: Shift from the Cyclic AMP to the Arachidonic Acid Pathway Mol. Pharmacol., November 1, 2003; 64(5): 1117 - 1125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.-P. Xiao, S.-J. Zhang, K. Chakir, P. Avdonin, W. Zhu, R. A. Bond, C. W. Balke, E. G. Lakatta, and H. Cheng Enhanced Gi Signaling Selectively Negates {beta}2-Adrenergic Receptor (AR)- but Not {beta}1-AR-Mediated Positive Inotropic Effect in Myocytes From Failing Rat Hearts Circulation, September 30, 2003; 108(13): 1633 - 1639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bartel, E.-G. Krause, G. Wallukat, and P. Karczewski New insights into {beta}2-adrenoceptor signaling in the adult rat heart Cardiovasc Res, March 1, 2003; 57(3): 694 - 703. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Kilts, T. Akazawa, M. D. Richardson, and M. M. Kwatra Age Increases Cardiac Galpha i2 Expression, Resulting in Enhanced Coupling to G Protein-coupled Receptors J. Biol. Chem., August 16, 2002; 277(34): 31257 - 31262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I.-K. S. Aggeli, C. Gaitanaki, A. Lazou, and I. Beis {alpha}1- and {beta}-adrenoceptor stimulation differentially activate p38-MAPK and atrial natriuretic peptide production in the perfused amphibian heart J. Exp. Biol., August 15, 2002; 205(16): 2387 - 2397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-H. Jo, V. Leblais, P. H. Wang, M. T. Crow, and R.-P. Xiao Phosphatidylinositol 3-Kinase Functionally Compartmentalizes the Concurrent Gs Signaling During {beta}2-Adrenergic Stimulation Circ. Res., July 12, 2002; 91(1): 46 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.-P. Xiao {beta}-Adrenergic Signaling in the Heart: Dual Coupling of the {beta}2-Adrenergic Receptor to Gs and Gi Proteins Sci. Signal., October 16, 2001; 2001(104): re15 - re15. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Houle, R. A. Altschuld, and G. E. Billman Enhanced in vivo and in vitro contractile responses to {beta}2-adrenergic receptor stimulation in dogs susceptible to lethal arrhythmias J Appl Physiol, October 1, 2001; 91(4): 1627 - 1637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-S. Zhang, H.-J. Cheng, T. Ukai, H. Tachibana, and C.-P. Cheng Enhanced Cardiac L-Type Calcium Current Response to beta 2-Adrenergic Stimulation in Heart Failure J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 188 - 196. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. M. Kaye, L. Johnston, G. Vaddadi, H. Brunner-LaRocca, G. L. Jennings, and M. D. Esler Mechanisms of Carvedilol Action in Human Congestive Heart Failure Hypertension, May 1, 2001; 37(5): 1216 - 1221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-E. Laurent, R. Cardinal, G. Rousseau, M. Vermeulen, C. Bouchard, M. Wilkinson, J. A. Armour, and M. Bouvier Functional desensitization to isoproterenol without reducing cAMP production in canine failing cardiocytes Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2001; 280(2): R355 - R364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-Y. Zhou, D. Yang, W.-Z. Zhu, S.-J. Zhang, D.-J. Wang, D. K. Rohrer, E. Devic, B. K. Kobilka, E. G. Lakatta, H. Cheng, et al. Spontaneous Activation of beta 2- but Not beta 1-Adrenoceptors Expressed in Cardiac Myocytes from beta 1beta 2 Double Knockout Mice Mol. Pharmacol., November 1, 2000; 58(5): 887 - 894. [Abstract] [Full Text]
|
|
|
|
|
|
Z. Nagykaldi, D. Kem, R. Lazzara, and B. Szabo Conditioning of beta 1-adrenoceptor effect via beta 2-subtype on L-type Ca2+ current in canine ventricular myocytes Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1329 - H1337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. G. Wang, A. M Samarel, and S. L Lipsius Laminin binding to {beta}1-integrins selectively alters {beta}1- and {beta}2-adrenoceptor signalling in cat atrial myocytes J. Physiol., August 15, 2000; 527(1): 3 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. He, G. Wu, and M. C. Lapointe Isoproterenol and cAMP regulation of the human brain natriuretic peptide gene involves Src and Rac Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1115 - E1123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Singh, C. Communal, D. B. Sawyer, and W. S. Colucci Adrenergic regulation of myocardial apoptosis Cardiovasc Res, February 1, 2000; 45(3): 713 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-Y. Zhou, L.-S. Song, E. G Lakatta, R.-P. Xiao, and H. Cheng Constitutive {beta}2-adrenergic signalling enhances sarcoplasmic reticulum Ca2+ cycling to augment contraction in mouse heart J. Physiol., December 1, 1999; 521(2): 351 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Cross, C. Steenbergen, R. J. Lefkowitz, W. J. Koch, and E. Murphy Overexpression of the Cardiac {beta}2-Adrenergic Receptor and Expression of a {beta}-Adrenergic Receptor Kinase-1 ({beta}ARK1) Inhibitor Both Increase Myocardial Contractility but Have Differential Effects on Susceptibility to Ischemic Injury Circ. Res., November 26, 1999; 85(11): 1077 - 1084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.-P. Xiao, H. Cheng, Y.-Y. Zhou, M. Kuschel, and E. G. Lakatta Recent Advances in Cardiac {beta}2-Adrenergic Signal Transduction Circ. Res., November 26, 1999; 85(11): 1092 - 1100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Steinberg The Molecular Basis for Distinct {beta}-Adrenergic Receptor Subtype Actions in Cardiomyocytes Circ. Res., November 26, 1999; 85(11): 1101 - 1111. [Full Text] [PDF]
|
|
|
|
|
|
Y.-Y. Zhou, H. Cheng, L.-S. Song, D. Wang, E. G. Lakatta, and R.-P. Xiao Spontaneous beta 2-Adrenergic Signaling Fails To Modulate L-Type Ca2+ Current in Mouse Ventricular Myocytes Mol. Pharmacol., September 1, 1999; 56(3): 485 - 493. [Abstract] [Full Text]
|
|
|
|
|
|
A. M. Feldman and C. McTiernan New Insight Into the Role of Enhanced Adrenergic Receptor-Effector Coupling in the Heart Circulation, August 10, 1999; 100(6): 579 - 582. [Full Text] [PDF]
|
|
|
|
|
|
M. A. Movsesian Beta-adrenergic receptor agonists and cyclic nucleotide phosphodiesterase inhibitors: shifting the focus from inotropy to cyclic adenosine monophosphate J. Am. Coll. Cardiol., August 1, 1999; 34(2): 318 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kuschel, Y.-Y. Zhou, H. Cheng, S.-J. Zhang, Y. Chen, E. G. Lakatta, and R.-P. Xiao Gi Protein-mediated Functional Compartmentalization of Cardiac beta 2-Adrenergic Signaling J. Biol. Chem., July 30, 1999; 274(31): 22048 - 22052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kuschel, Y.-Y. Zhou, H. A. Spurgeon, S. Bartel, P. Karczewski, S.-J. Zhang, E.-G. Krause, E. G. Lakatta, and R.-P. Xiao ß2-Adrenergic cAMP Signaling Is Uncoupled From Phosphorylation of Cytoplasmic Proteins in Canine Heart Circulation, May 11, 1999; 99(18): 2458 - 2465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Schroder and S. Herzig Effects of beta 2-adrenergic stimulation on single-channel gating of rat cardiac L-type Ca2+ channels Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H834 - H843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.-P. Xiao, P. Avdonin, Y.-Y. Zhou, H. Cheng, S. A. Akhter, T. Eschenhagen, R. J. Lefkowitz, W. J. Koch, and E. G. Lakatta Coupling of ß2-Adrenoceptor to Gi Proteins and Its Physiological Relevance in Murine Cardiac Myocytes Circ. Res., January 22, 1999; 84(1): 43 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kaumann, S. Bartel, P. Molenaar, L. Sanders, K. Burrell, D. Vetter, P. Hempel, P. Karczewski, and E.-G. Krause Activation of ß2-Adrenergic Receptors Hastens Relaxation and Mediates Phosphorylation of Phospholamban, Troponin I, and C-Protein in Ventricular Myocardium From Patients With Terminal Heart Failure Circulation, January 12, 1999; 99(1): 65 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pavoine, S. Magne, A. Sauvadet, and F. Pecker Evidence for a beta 2-Adrenergic/Arachidonic Acid Pathway in Ventricular Cardiomyocytes. REGULATION BY THE beta 1-ADRENERGIC/cAMP PATHWAY J. Biol. Chem., January 8, 1999; 274(2): 628 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. K. B. SIMMERMAN and L. R. JONES Phospholamban: Protein Structure, Mechanism of Action, and Role in Cardiac Function Physiol Rev, October 1, 1998; 78(4): 921 - 947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. L. Grupp, J. N. Lorenz, R. A. Walsh, G. P. Boivin, and H. Rindt Overexpression of alpha 1B-adrenergic receptor induces left ventricular dysfunction in the absence of hypertrophy Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1338 - H1350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. New, J. L. Zellner, L. Hebbar, R. Mukherjee, A. C. Sampson, J. W. Hendrick, J. R. Handy, F. Crawford Jr., and F. G. Spinale Isolated left ventricular myocyte contractility in patients undergoing cardiac operations J. Thorac. Cardiovasc. Surg., September 1, 1998; 116(3): 495 - 499. [Abstract] [Full Text]
|
|
|
|
|
|
M. Fukuchi, S. N. A. Hussain, and A. Giaid Heterogeneous Expression and Activity of Endothelial and Inducible Nitric Oxide Synthases in End-Stage Human Heart Failure : Their Relation to Lesion Site and ß-Adrenergic Receptor Therapy Circulation, July 14, 1998; 98(2): 132 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. A. Skeberdis and a. R. Fischmeister Beta-2 Adrenergic Activation of L-Type Ca++ Current in Cardiac Myocytes J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 452 - 461. [Abstract] [Full Text]
|
|
|
|
|
|
L. C. Hool and R. D. Harvey Role of beta 1- and beta 2-adrenergic receptors in regulation of Cl- and Ca2+ channels in guinea pig ventricular myocytes Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1669 - H1676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. E. Billman, L. C. Castillo, J. Hensley, C. M. Hohl, and R. A. Altschuld ß2-Adrenergic Receptor Antagonists Protect Against Ventricular Fibrillation : In Vivo and In Vitro Evidence for Enhanced Sensitivity to ß2-Adrenergic Stimulation in Animals Susceptible to Sudden Death Circulation, September 16, 1997; 96(6): 1914 - 1922. [Abstract] [Full Text]
|
|
|
|
|
|
S. Pepe, R.-P. Xiao, C. Hohl, R. Altschuld, and E. G. Lakatta `Cross Talk' Between Opioid Peptide and Adrenergic Receptor Signaling in Isolated Rat Heart Circulation, April 15, 1997; 95(8): 2122 - 2129. [Abstract] [Full Text]
|
|
|
|
|
|
J. Bartunek, A. M. Shah, M. Vanderheyden, and W. J. Paulus Dobutamine Enhances Cardiodepressant Effects of Receptor-Mediated Coronary Endothelial Stimulation Circulation, January 7, 1997; 95(1): 90 - 96. [Abstract] [Full Text]
|
|
|
|
|
|
W. J. Koch, C. A. Milano, and R. J. Lefkowitz Transgenic Manipulation of Myocardial G Protein–Coupled Receptors and Receptor Kinases Circ. Res., April 1, 1996; 78(4): 511 - 516. [Full Text]
|
|
|
|
|
|
D. Hagemann, M. Kuschel, T. Kuramochi, W. Zhu, H. Cheng, and R.-P. Xiao Frequency-encoding Thr17 Phospholamban Phosphorylation Is Independent of Ser16 Phosphorylation in Cardiac Myocytes J. Biol. Chem., July 14, 2000; 275(29): 22532 - 22536. [Abstract] [Full Text] [PDF]
|
|